Apoptosis and cancer: the genesis of a research field - PubMed (original) (raw)

Review

doi: 10.1038/nrc2663.

Affiliations

• PMID: 19550425
• DOI: 10.1038/nrc2663

Review

Apoptosis and cancer: the genesis of a research field

Thomas G Cotter. Nat Rev Cancer. 2009 Jul.

Abstract

In multicellular organisms, the total number of cells is a balance between the cell-generating effects of mitosis and cell death that is induced through apoptosis. A disruption of this delicate balance can lead to the development of cancer. This Timeline article focuses on how the field of apoptosis biology has developed in the context of its contribution to our understanding of cell death, or lack of it, in the development of malignant disease. It traces the course of research from key discoveries in fundamental biology to potential therapeutic applications.

PubMed Disclaimer

Similar articles

• Mutations in apoptosis genes: a pathogenetic factor for human disease.
  Müllauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. Müllauer L, et al. Mutat Res. 2001 Jul;488(3):211-31. doi: 10.1016/s1383-5742(01)00057-6. Mutat Res. 2001. PMID: 11397650 Review.
• MYC and the control of apoptosis.
  McMahon SB. McMahon SB. Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a014407. doi: 10.1101/cshperspect.a014407. Cold Spring Harb Perspect Med. 2014. PMID: 24985130 Free PMC article. Review.
• Functional aspects of apoptosis in hematopoiesis and consequences of failure.
  McKenna SL, Cotter TG. McKenna SL, et al. Adv Cancer Res. 1997;71:121-64. doi: 10.1016/s0065-230x(08)60098-6. Adv Cancer Res. 1997. PMID: 9111865 Review.
• Apoptosis induced by MNNG in human TK6 lymphoblastoid cells is p53 and Fas/CD95/Apo-1 related.
  Dunkern T, Roos W, Kaina B. Dunkern T, et al. Mutat Res. 2003 Nov;544(2-3):167-72. doi: 10.1016/j.mrrev.2003.06.005. Mutat Res. 2003. PMID: 14644318

Cited by

• Potential treatment of inflammatory and proliferative diseases by ultra-low doses of ionizing radiations.
  Sanders CL. Sanders CL. Dose Response. 2012 Dec;10(4):610-25. doi: 10.2203/dose-response.12-017.Sanders. Epub 2012 Oct 9. Dose Response. 2012. PMID: 23304108 Free PMC article.
• Endosomolytic reducible polymeric electrolytes for cytosolic protein delivery.
  Tian L, Kang HC, Bae YH. Tian L, et al. Biomacromolecules. 2013 Aug 12;14(8):2570-81. doi: 10.1021/bm400337f. Epub 2013 Jul 11. Biomacromolecules. 2013. PMID: 23841591 Free PMC article.
• TRAIL and Cardiovascular Disease-A Risk Factor or Risk Marker: A Systematic Review.
  Kakareko K, Rydzewska-Rosołowska A, Zbroch E, Hryszko T. Kakareko K, et al. J Clin Med. 2021 Mar 18;10(6):1252. doi: 10.3390/jcm10061252. J Clin Med. 2021. PMID: 33803523 Free PMC article. Review.
• Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.
  Dilip A, Cheng G, Joseph J, Kunnimalaiyaan S, Kalyanaraman B, Kunnimalaiyaan M, Gamblin TC. Dilip A, et al. Anticancer Drugs. 2013 Oct;24(9):881-8. doi: 10.1097/CAD.0b013e32836442c6. Anticancer Drugs. 2013. PMID: 23872912 Free PMC article.
• The pro-survival function of DLEC1 and its protection of cancer cells against 5-FU-induced apoptosis through up-regulation of BCL-XL.
  Qiu GH, Que W, Yan S, Zheng X, Xie X, Huang C, Yang X, Hooi SC. Qiu GH, et al. Cytotechnology. 2019 Feb;71(1):23-33. doi: 10.1007/s10616-018-0258-9. Epub 2019 Jan 3. Cytotechnology. 2019. PMID: 30607648 Free PMC article.

References

1. 1. Cell. 2000 Jul 7;102(1):33-42 - PubMed
2. 1. Cell. 1995 Jan 27;80(2):285-91 - PubMed
3. 1. Nature. 1991 Jul 25;352(6333):345-7 - PubMed
4. 1. Nature. 1988 Nov 17;336(6196):259-61 - PubMed
5. 1. Br J Cancer. 1998 Sep;78(6):812-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database